Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Keyword
-
- Aluminum (3)
- Animals (3)
- Atomic (3)
- Inbred F344 (3)
- Proteomics (3)
-
- Rats (3)
- Rats, Inbred F344 (3)
- Spectrophotometry (3)
- Spectrophotometry, Atomic (3)
- Accelerator mass spectrometry (2)
- Biological Availability (2)
- Data Interpretation (2)
- Data Interpretation, Statistical (2)
- Male (2)
- Radioisotopes (2)
- Statistical (2)
- 14C (1)
- 26Al (1)
- Aluminum Compounds (1)
- Aluminum Oxide (1)
- Aluminum bioavailability (1)
- Antioxidants (1)
- Area Under Curve (1)
- Atomic absorption spectrometry (1)
- Blood-Brain Barrier (1)
- Brain (1)
- Carbon Radioisotopes (1)
- Cerebrovascular Circulation (1)
- Cheese (1)
- Chemical species (1)
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
Manufactured Aluminum Oxide Nanoparticles Decrease Expression Of Tight Junction Proteins In Brain Vasculature, Lei Chen, Robert A. Yokel, Bernhard Hennig, Michal Toborek
Manufactured Aluminum Oxide Nanoparticles Decrease Expression Of Tight Junction Proteins In Brain Vasculature, Lei Chen, Robert A. Yokel, Bernhard Hennig, Michal Toborek
Pharmaceutical Sciences Faculty Publications
Manufactured nanoparticles of aluminum oxide (nano-alumina) have been widely used in the environment; however, their potential toxicity provides a growing concern for human health. The present study focuses on the hypothesis that nano-alumina can affect the blood-brain barrier and induce endothelial toxicity. In the first series of experiments, human brain microvascular endothelial cells (HBMEC) were exposed to alumina and control nanoparticles in dose- and time-responsive manners. Treatment with nano-alumina markedly reduced HBMEC viability, altered mitochondrial potential, increased cellular oxidation, and decreased tight junction protein expression as compared to control nanoparticles. Alterations of tight junction protein levels were prevented by cellular …
Aluminum Bioavailability From Tea Infusion, Robert A. Yokel, Rebecca L. Florence
Aluminum Bioavailability From Tea Infusion, Robert A. Yokel, Rebecca L. Florence
Pharmaceutical Sciences Faculty Publications
The objective was to estimate oral Al bioavailability from tea infusion in the rat, using the tracer 26Al. 26Al citrate was injected into tea leaves. An infusion was prepared from the dried leaves and given intra-gastrically to rats which received concurrent intravenous 27Al infusion. Oral Al bioavailability (F) was calculated from the area under the 26Al, compared to 27Al, serum concentration × time curves. Bioavailability from tea averaged 0.37%; not significantly different from water (F = 0.3%), or basic sodium aluminum phosphate (SALP) in cheese (F = 0.1 to 0.3%), but greater than acidic SALP …
Identification Of Highly Expressed, Soluble Proteins Using An Improved, High-Throughput Pooled Orf Expression Technology, Timothy Waybright, William Gillette, Dominic Esposito, Robert Stephens, David Lucas, James Hartley, Timothy D. Veenstra
Identification Of Highly Expressed, Soluble Proteins Using An Improved, High-Throughput Pooled Orf Expression Technology, Timothy Waybright, William Gillette, Dominic Esposito, Robert Stephens, David Lucas, James Hartley, Timothy D. Veenstra
Pharmaceutical Sciences Faculty Publications
This article describes an improved pooled open reading frame (ORF) expression technology (POET) that uses recombinational cloning and solution-based tandem mass spectrometry (MS/MS) to identify ORFs that yield high levels of soluble, purified protein when expressed in Escherichia coli. Using this method, three identical pools of 512 human ORFs were subcloned, purified, and transfected into three separate E. coli cultures. After bulk expression and purification, the proteins from the three separate pools were digested into tryptic peptides. Each of these samples was subsequently analyzed in triplicate using reversed-phase high-performance liquid chromatography (LC) coupled directly online with MS/MS. The abundance of …
Aluminum Bioavailability From Basic Sodium Aluminum Phosphate, An Approved Food Additive Emulsifying Agent, Incorporated In Cheese, Robert A. Yokel, Clair L. Hicks, Rebecca L. Florence
Aluminum Bioavailability From Basic Sodium Aluminum Phosphate, An Approved Food Additive Emulsifying Agent, Incorporated In Cheese, Robert A. Yokel, Clair L. Hicks, Rebecca L. Florence
Pharmaceutical Sciences Faculty Publications
Oral aluminum (Al) bioavailability from drinking water has been previously estimated, but there is little information on Al bioavailability from foods. It was suggested that oral Al bioavailability from drinking water is much greater than from foods. The objective was to further test this hypothesis. Oral Al bioavailability was determined in the rat from basic [26Al]-sodium aluminum phosphate (basic SALP) in a process cheese. Consumption of approximately 1g cheese containing 1.5% or 3% basic SALP resulted in oral Al bioavailability (F) of approximately 0.1% and 0.3%, respectively, and time to maximum serum 26Al concentration (Tmax) of 8-9h. These Al bioavailability …
The Influence Of Citrate, Maltolate And Fluoride On The Gastrointestinal Absorption Of Aluminum At A Drinking Water-Relevant Concentration: A 26Al And 14C Study, Yuzhao Zhou, Wesley R. Harris, Robert A. Yokel
The Influence Of Citrate, Maltolate And Fluoride On The Gastrointestinal Absorption Of Aluminum At A Drinking Water-Relevant Concentration: A 26Al And 14C Study, Yuzhao Zhou, Wesley R. Harris, Robert A. Yokel
Pharmaceutical Sciences Faculty Publications
The objectives were to test the null hypotheses that (1) citrate, maltolate, and fluoride do not significantly influence oral Al bioavailability, Cmax or Tmax at an Al dose relevant to drinking water exposure; and (2) Al citrate and maltolate are absorbed intact from the gastrointestinal tract. Male Fisher rats were given 1 ml of solution intra-gastrically containing 1 nCi 26Al (65 nmol total Al) as the Al3+ ion, or as complexes with 14C-citrate, 14C-maltolate or fluoride, during concurrent 27Al iv infusion. Blood was repeatedly collected for serum 26Al, total Al and 14 …
Two-Dimensional Polyacrylamide Gel Electrophoresis (2d-Page): Advances And Perspectives, Haleem Issaq, Timothy D. Veenstra
Two-Dimensional Polyacrylamide Gel Electrophoresis (2d-Page): Advances And Perspectives, Haleem Issaq, Timothy D. Veenstra
Pharmaceutical Sciences Faculty Publications
The recent trend in science is to assay as many biological molecules as possible within a single experiment. This trend is evident in proteomics where the aim is to characterize thousands of proteins within cells, tissues, and organisms. While advances in mass spectrometry have been critical, developments made in two-dimensional PAGE (2D-PAGE) have also played a major role in enabling proteomics. In this review, we discuss and highlight the advances made in 2D-PAGE over the past 25 years that have made it a foundational tool in proteomic research.
Mass Spectrometry: M/Z 1983-2008, Ming Zhou, Timothy D. Veenstra
Mass Spectrometry: M/Z 1983-2008, Ming Zhou, Timothy D. Veenstra
Pharmaceutical Sciences Faculty Publications
While definitely not a new technology, mass spectrometry (MS) has seen incredible growth over the past 25 years. Mass spectrometry has rapidly evolved to the forefront of analytical techniques; its ability to analyze proteins is the major driving force in the field of proteomics. MS instrumentation has increased approximately 5-fold in sensitivity every three years. The level of performance that is achievable with MS today allows scientists to study proteins in ways that were inconceivable a quarter century ago. This review of the history of MS over the past 25 years is timely in that it encompasses two of the …